home / stock / tbio / tbio quote
Last: | $0.3214 |
---|---|
Change Percent: | -2.24% |
Open: | $0.3285 |
Close: | $0.3214 |
High: | $0.34 |
Low: | $0.3121 |
Volume: | 23,045 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.3214 | $0.3285 | $0.3214 | $0.34 | $0.3121 | 23,045 | 04-25-2024 |
$0.3213 | $0.301 | $0.3213 | $0.35 | $0.301 | 127,696 | 04-24-2024 |
$0.3235 | $0.339 | $0.3235 | $0.339 | $0.31 | 138,794 | 04-23-2024 |
$0.3152 | $0.2997 | $0.3152 | $0.3338 | $0.2997 | 70,346 | 04-22-2024 |
$0.309 | $0.32 | $0.309 | $0.35 | $0.3 | 162,776 | 04-19-2024 |
$0.331 | $0.3824 | $0.331 | $0.4641 | $0.3116 | 266,587 | 04-18-2024 |
$0.38 | $0.380001 | $0.38 | $0.4 | $0.355 | 24,942 | 04-17-2024 |
$0.3675 | $0.366 | $0.3675 | $0.4158 | $0.35 | 53,731 | 04-16-2024 |
$0.3777 | $0.3851 | $0.3777 | $0.4171 | $0.36 | 32,473 | 04-15-2024 |
$0.41 | $0.425 | $0.41 | $0.43 | $0.4089 | 31,857 | 04-12-2024 |
$0.4362 | $0.43 | $0.4362 | $0.455 | $0.4225 | 28,907 | 04-11-2024 |
$0.4265 | $0.43 | $0.4265 | $0.4567 | $0.4252 | 24,314 | 04-10-2024 |
$0.4301 | $0.4314 | $0.4301 | $0.4622 | $0.4224 | 37,947 | 04-09-2024 |
$0.4307 | $0.453 | $0.4307 | $0.462 | $0.4225 | 14,918 | 04-08-2024 |
$0.44 | $0.4505 | $0.44 | $0.4678 | $0.44 | 18,935 | 04-05-2024 |
$0.461 | $0.469 | $0.461 | $0.469 | $0.44 | 35,825 | 04-04-2024 |
$0.477 | $0.44 | $0.477 | $0.4785 | $0.4159 | 39,637 | 04-03-2024 |
$0.4385 | $0.43 | $0.4385 | $0.448 | $0.43 | 23,241 | 04-02-2024 |
$0.4356 | $0.43 | $0.4356 | $0.4582 | $0.4138 | 65,534 | 04-01-2024 |
$0.44 | $0.4325 | $0.44 | $0.45 | $0.4325 | 42,607 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will in...
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own lab, today announced financial results for the...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...